Wall Street stocks closed higher on Wednesday as major indices tried to reclaim record highs in one of the final sessions of the year.
London stocks reversed earlier small gains to end lower on Wednesday despite news that AstraZeneca’s Covid-19 vaccine has been given the green light and MPs’ passing of the Brexit deal, as millions more people in England were set to enter tougher Tier 4 restrictions.
European shares slid into the red at the close on Wednesday, ending a five-day run of gains as tougher Covid-19 restrictions in the UK hit sentiment, despite a new vaccine approval for AstraZeneca.
British lawmakers on Wednesday approved a deal governing the UK's trade relationship with the European Union.
Wall Street stocks opened higher on Wednesday as major indices looked set to attempt to reclaim some of their record highs in one of the final sessions of the year.
US pending home sales fell in November, according to data released on Wednesday by the National Association of Realtors.
Economic activity in the Chicago area unexpectedly picked up in December, according to data released on Wednesday.
Beijing is reportedly accelerating plans to bring Jack Ma’s Ant Group more closely under its control as part of a “rectification” drive that would make it difficult for one of China’s richest men to fully rebuild his online empire.
CCTV group Univision has signed a fourth supplementary agreement to its contract with the MTR Corporation in Hong Kong.
Chinese Covid-19 vaccine developer Sinopharm said it will seek approval from regulators after final stage trials showed a 79% efficacy rate.
Wall Street futures had stocks opening higher ahead of the bell on Wednesday as major indices looked set to attempt to reclaim some of their record highs in one of the final sessions of the year.
European shares were mixed at midday on Wednesday as investors eyed the outcome of a UK parliamentary vote on the Brexit trade deal amid new concerns over tougher coronavirus restrictions.
European shares rose slightly at the opening on Wednesday, as the UK government approved the AstraZeneca/Oxford Covid-19 vaccine.
London stocks had nudged just a touch higher by midday on Wednesday, having hit their highest level since March a day earlier on the back of the Brexit trade deal and US stimulus package.
Exploration and development firm Uru Metals said on Wednesday that first-half losses had widened as a result of higher costs and the settlement of debts.
The Oxford University/AstraZeneca Covid-19 vaccine has been approved for use in the UK, with vaccinations set to begin early in the New Year.
Oil and gas engineering services business Plexus provided investors with an update at its annual general meeting on Wednesday.
London stocks were little changed in early trade on Wednesday after strong gains in the previous session, which saw the FTSE 100 hit its highest level since March as investors cheered the Brexit trade deal and US stimulus package.
Management consulting company MJ Hudson has acquired fund performance analytics specialist Prof Gottschalg UG and its subsidiary PERACS.
Annual house price growth continued to accelerate in December, reaching a six-year high of 7. 3%, according to Nationwide's house price index, up from 6. 5% in the preceding month.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.